Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v8-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-04-13 | 2022-11-02 |
| Drug Identification Number | 02246226 | 02246226 |
| Brand name | FLUDARA | FLUDARA |
| Common or Proper name | Fludarabine phosphate | Fludarabine phosphate |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | FLUDARABINE PHOSPHATE | FLUDARABINE PHOSPHATE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 4 Blister packs | 4 Blister packs |
| ATC code | L01BB | L01BB |
| ATC description | ANTIMETABOLITES | ANTIMETABOLITES |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2022-09-01 | 2022-09-01 |
| Actual start date | 2022-09-01 | 2022-09-01 |
| Estimated end date | 2023-03-31 | 2023-03-31 |
| Actual end date | 2023-03-31 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | Yes |
| Company comments | Allocation has been initiated and may continue through March 2023. | Allocation has been initiated and may continue through March 2023. |
| Health Canada comments |